During this past preschool year, my son said to me a few times that he wished his friends understood his body.“ View Entire ...

ENvue Medical, Inc. (NASDAQ: FEED) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in non-invasive therapeutic systems, today announced that the UroShield® Kit ...

CorMedix and USRC commenced the real-world evidence study upon outpatient commercial launch in July 2024. The study is designed to demonstrate the impact of the broad use of DefenCath in a real-world ...

Derrek Cooke, who was born with Spina Bifida, speaks with “Enable: The Disability Podcast” about what it means to be a “Spina ...

Medtronic reported that its new thrombectomy system, aimed at removing blood clots from the arms and legs, has begun its ...

The FDA said it plans to accept new forms of real-world evidence in product applications, starting with a subset of medical ...

A land of ingenuity and invention; a land where every person seeks to get out of work, and miraculously many are quite ...

Only 30% of hospital leaders expect balance sheets to improve next year as health systems grapple with costs and changes to ...

Johnson & Johnson MedTech will be one of several companies set to benefit from a new CMS decision related to pulsed field ...

They manage to slow down the progression of Huntington's disease using a gene therapy treatment called AMT 130.

The OEM arm is sold to private equity firms Montagu and Kohlberg, while UK-based Intersurgical will take over the other two ...

As of Tuesday, December 09, Teleflex Incorporated’s TFX share price has surged by 9.03%, which has investors questioning if this is right time to sell.